GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » InnoCan Pharma Corp (XCNQ:INNO) » Definitions » Valuation Rank

InnoCan Pharma (XCNQ:INNO) Valuation Rank


View and export this data going back to 2019. Start your Free Trial

What is InnoCan Pharma Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

InnoCan Pharma Valuation Rank Related Terms

Thank you for viewing the detailed overview of InnoCan Pharma's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

InnoCan Pharma (XCNQ:INNO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » InnoCan Pharma Corp (XCNQ:INNO) » Definitions » Valuation Rank
Comparable Companies
TSXV:LOVE TSX:CRDL TSXV:RX XCNQ:GRIN TSXV:ZYUS TSX:CPH TSXV:DB XCNQ:JUSH XCNQ:AYR.A XCNQ:HUGE ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
INNPF:USA IP4:Germany
Address
1015, 926 - 5 Avenue SW, Calgary, AB, CAN, T2P 0N7
Website
https://www.innocanpharma.com
InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue from the United States.